Navigation Links
Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care
Date:5/30/2009

es the dissemination of information about cancer and cancer treatment to patients and their families; and, through its grant program, supports, encourages and recognizes excellence in clinical research in the field of oncology.

About Wyeth Pharmaceuticals

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, among others, risks related to our proposed merger with Pfizer, including satisfaction of the conditions of the proposed merger on the proposed timeframe or at all, contractual restrictions on the conduct of our business included in the merger agreement, and the potential for loss of key personnel, disruption in key business activities or any impact on our relationships with third parties as a result of the announcement of the proposed merger; the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory approval and commercialization of our products and pipeline products; government cost-containment
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. U.S. and 16 States Join Suits Against Pharmaceutical Giant, Wyeth
2. Wyeth Reports Earnings Results for the 2009 First Quarter
3. Gene Network Sciences Names Former Wyeth President of R&D Robert Ruffolo to SAB
4. Wyeths CONBRIZA Approved in the European Union for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
5. Wyeth Reduces Risk with Dyadem Software
6. Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers
7. FDA Approves New Indication for Wyeths TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
8. DRI - the Voice of the Defense Bar Responds to Supreme Court Ruling in Wyeth v. Levine
9. Wyeth Comments on U.S. Supreme Court Ruling in Levine Preemption Case
10. NJLRA Statement on Todays U.S. Supreme Courts Decision in Wyeth v. Levine
11. Wyeth Reports Earnings Results for the 2008 Full Year and Fourth Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... NEW YORK (17 April 2014) Population Council scientists and ... is safe, stable, and can prevent the transmission of ... and rectum in animals: HIV, herpes simplex virus 2 ... provides the first data that the gel is effective ... of efficacy in the vagina against all three viruses ...
(Date:4/17/2014)... flow and alleviates muscle soreness after exercise, according ... of Illinois at Chicago. , The study, reported ... Archives of Physical Medicine and Rehabilitation , also ... who had not exercised, suggesting that massage has ... physical activity. , Improved circulation and relief of ...
(Date:4/17/2014)... TORONTO, April 17, 2014While 94 per cent of Canadians ... that screen newborns for a specific number of genetic ... willing to participate in screening that would sequence their ... prick test" in their first day or two of ... taken from their heels and tested for about five ...
(Date:4/17/2014)... lost its status as the leading weapon against the ... life, with new research indicating it simply needs to ... use of the cheap anti-malarial drug chloroquine in treating ... of more than half a million people each year ... has developed resistance to chloroquine, but research carried out ...
(Date:4/16/2014)... , PHOENIX, Ariz. April 15, 2014 The ... Arizona philanthropists at their annual Founders Dinner for their ... cancer. The event took place March 28 in Scottsdale. ... & Catherine Ivy Foundation, received TGen,s John S. McCain ...
Breaking Medicine News(10 mins):Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2Health News:Massage therapy improves circulation, eases muscle soreness 2Health News:Researcher looks at public perceptions around newborn testing 2Health News:Researcher looks at public perceptions around newborn testing 3Health News:Scientists find new way to fight malaria drug resistance 2Health News:TGen honors Catherine Ivy and Craig Jackson with Leadership; Collaborative Spirit awards 2
... 27 Accuray,Incorporated (Nasdaq: ARAY ), a global ... senior vice president and chief financial officer,Robert E. McNamara, ... Company Ninth,Annual Investor Conference at the Palms Casino & ... 8:00 a.m. PDT (11:00 a.m. EDT)., A live ...
... discussed by international experts, WASHINGTON, March 27 ... the first time, bring together leading heart,disease and stroke ... income, education and geography can predict how healthy we ... held March 28 on the campus of George Washington,University, ...
... MOORESTOWN, N.J., March 27 In response ... problem with medication use in the United,States, ... Rasa,Strategies(TM), LLC (TR-Strategies(TM)), a pharmaceutical care consulting,firm ... practice, to help,organizations develop strategies to implement ...
... 20 Global Pharmaceutical Company Licenses Public-Source Database to, Quantify ... ... Development, MOUNTAIN VIEW, Calif., March 27 ... and regulatory services for optimizing clinical drug,development, today announced that it ...
... Congressman for Formally Opposing Deep,Cuts to Medicare,s Home ... Pacific Pulmonary,Services - Ukiah Center, a provider of ... more than 200 patients in Ukiah and the,surrounding ... with patients, physicians and technicians to discuss the ...
... Election 2008 Resources for Voters on Health Care ... American Academy of,Actuaries said the most recent Medicare ... program,s long-term financing issues.,According to the program,s trustees, ... payroll taxes, and Medicare must,rely also on interest ...
Cached Medicine News:Health News:Accuray's CFO to Present at B. Riley & Company Ninth Annual Investor Conference 2Health News:Groundbreaking Town Hall Meeting to Explore Why Race, Income and Geography Can Predict Health 2Health News:Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A 'Clean Slate' Approach to the Practice of Pharmaceutical Care 2Health News:Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A 'Clean Slate' Approach to the Practice of Pharmaceutical Care 3Health News:Pharsight Signs New Diabetes Meta-Database Customer 2Health News:Pharsight Signs New Diabetes Meta-Database Customer 3Health News:Ukiah Home Oxygen Therapy Patients and Physicians Meet with Congressman Mike Thompson to Share Benefits of Quality Home Oxygen Care 2Health News:Ukiah Home Oxygen Therapy Patients and Physicians Meet with Congressman Mike Thompson to Share Benefits of Quality Home Oxygen Care 3Health News:Medicare Trustees' Report Highlights Need for Reform 2
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... India Drug Forecast and Market Analysis to ... PharmaPoint: Atopic Dermatitis - India Drug ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... market research report is available in ... Global Markets and Technologies for Advanced ... Routes of Administration ...
(Date:1/14/2014)... Jan. 14, 2014 HeartWare International, Inc . ... less invasive, miniaturized circulatory support technologies that are revolutionizing ... it expects revenues for the fourth quarter of 2013 ... revenues to approximately $208 million. "Our full-year ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... WellPoint, Inc. (NYSE: WLP ) is the first ... guidelines that it will use when evaluating drugs for purposes of ... plans. , , , ... guidelines in the public domain, we are providing some guidance to pharmaceutical ...
... PFE ) invites investors and the general public to view and listen to a ... at the Citi 2010 Global Healthcare Conference on Wednesday, May 26, 2010 , at ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO ... To view and listen to the webcast, ...
Cached Medicine Technology:WellPoint Is First Health Benefits Company to Release CER Guidelines for Use in Evaluating Pharmaceuticals 2WellPoint Is First Health Benefits Company to Release CER Guidelines for Use in Evaluating Pharmaceuticals 3WellPoint Is First Health Benefits Company to Release CER Guidelines for Use in Evaluating Pharmaceuticals 4Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference 2
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... ergonomics, and value!, Comfortable feel ... non-slip, contoured handle , Finer control ... spring action , Completely autoclavable for ... need for recalibration , Easy-to-read precision ...
Inquire...
Medicine Products: